People on the Move – Nov. 25
People on the Move is a rundown of recent hirings, promotions, appointments and other notable movements by professionals in the state. If you’re interested in submitting an entry, please contact email@example.com.
WSFS Financial Corporation, the parent company of WSFS Bank, today announced the appointment of Nancy J. Foster, President and Chief Executive Officer of The Risk Management Association, to its Board of Directors, effective November 23, 2020. Foster will also serve on the Board’s Executive Committee. She will stand for election at the 2021 Annual Meeting of Stockholders.
“We are grateful to have a leader with Nancy’s broad range of experience in commercial banking, risk management and lending, as well as her significant expertise in business transformation join our Board of Directors. She will be an immediate asset to WSFS as we continue our strategic growth,” said Rodger Levenson, WSFS’ Chairman, President and Chief Executive Officer in a statement. “Periodically adding Board Directors is consistent with our ongoing philosophy of refreshment with the objective of bringing new ideas, perspectives and business acumen to complement the Board.”
Foster has served as President and CEO of The Risk Management Association since 2018, where she has worked with the board, chapters, regulators and institutional members to advance sound risk management practices among the 100-year-old association’s more than 1,900 financial institutions, which collectively represent 85 percent of bank assets in the U.S. and Canada. Foster has nearly forty years of experience in commercial banking and risk management.
Prior to joining The Risk Management Association, Foster was Executive Vice President, Chief Risk Officer and Head of Personal Financial Services at Park Sterling Bank. She was previously Chief Risk Officer of CIT Group, Inc., where she was responsible for global, enterprise-wide risk management. Prior to joining CIT, Foster was Group Senior Vice President at LaSalle Bank Corporation. During her tenure at LaSalle, she held several roles of increasing responsibility in middle market lending and credit risk management.
Foster received her master’s degree in business administration in finance and strategy from the University of Chicago Booth School of Business and her bachelor’s degrees in finance and economics from Illinois State University.
The Fresh Start Scholarship Foundation recently elected three new Board of Directors. Adding to our all-female volunteer-led board, Fresh Start is pleased to add the following individuals:
Dr. Lucia Nemeth, Associate Professor at Wilmington University, will serve as Chair of Database Management.
Adrienne Wallace, Vice President of Community Engagement and Wellness for the Community Education Building, will serve as Chair of our Annual Campaign.
Marisa Facciolo, SVP and Regional Director of Relationship Strategy for Hawthorn, PNC Family Wealth, will serve as Chair of Governance.
Each Board of Director will serve a three-year term in their respective role.
Tandy Tipps Ph. D., has been appointed to lead Inteliquet’s relationships and solutions development with healthcare organizations and cancer centers. Tipps will focus on advancing a site-centric approach to patient matching for clinical trials and precision medicine through a combination of powerful technology, analytics, and clinical research expertise. Dr. Tipps, who will serve as Inteliquet’s Senior Vice President, Healthcare Organizations Solutions, has more than 25 years leading oncology clinical research initiatives and developing global research site networks.
Most recently Dr. Tipps developed and led the Oncology Site Network at Precision for Medicine, which is a global oncology site network consisting of 74 sites. Previously, she was the Administrative Director of the world’s largest Phase 1 program at UT MD Anderson Cancer Center in Houston, Texas.
Dr. Tipps stated, “I have always been driven by an impatience with the barriers that prevent cancer patients from potential life-saving therapies due to a lack of unbridled access to clinical trials. Inteliquet’s unparalleled OncWeb™ platform eliminates these barriers and provides treatment options to patients that might not otherwise have them.”
Dr. Tipps also noted, “Cancer centers are challenged because they do not constantly receive the technology and support they need to accurately match the right patient to the right drug, while also ensuring data quality and compliance. Inteliquet meets this challenge and supports sites. We value our site relationships and view them as the bedrock to beating cancer.”